SCHEDULE 13G/A: BlackRock Reports 11.3% Stake in Inspire Medical Systems
Amendment to Beneficial Ownership Report (Schedule 13G)
BlackRock, Inc. has filed an amendment to its Schedule 13G, disclosing an 11.3% beneficial ownership stake in Inspire Medical Systems Inc.
Summary
- BlackRock, Inc. reported beneficial ownership of 3,353,407 shares of common stock in Inspire Medical Systems Inc.
- This represents an 11.3% stake in the company's common stock.
- BlackRock holds sole voting power over 3,283,122 shares and sole dispositive power over 3,353,407 shares.
- The filing is an Amendment No. 6 to a Schedule 13G statement, indicating ongoing reporting of its ownership.
- The securities were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing control of the issuer.
- iShares Core S&P Small-Cap ETF, a BlackRock entity, is noted as beneficially owning more than 5% of the outstanding common stock.
- The filing includes a new Power of Attorney executed on January 21, 2025, which revokes a previous Power of Attorney dated April 30, 2023.
Sentiment
Score: 5
Explanation: Neutral, as this is a standard disclosure of institutional ownership and does not contain performance or forward-looking statements about the issuer's operations or financial health.
Future Outlook
This filing does not contain any forward-looking statements or guidance regarding Inspire Medical Systems Inc.'s future performance or outlook.
Management Comments
- BlackRock, Inc. certifies that, to the best of its knowledge and belief, the securities were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer.
Industry Context
This filing reflects a significant institutional investment by BlackRock, one of the world's largest asset managers, in Inspire Medical Systems Inc., a company operating in the medical device sector, specifically focusing on sleep apnea treatments. Such disclosures provide transparency into major institutional holdings within the industry.
Stakeholder Impact
- Shareholders: Provides transparency regarding a significant institutional investor's stake, potentially signaling institutional confidence in Inspire Medical Systems Inc.
- Employees, customers, suppliers, creditors: No direct impact from this ownership disclosure.
Key Dates
| Date | Description |
|---|---|
| 2023-04-30 | Previous Power of Attorney revoked by the new Power of Attorney. |
| 2025-01-21 | Execution date of the current Power of Attorney by BlackRock, Inc. |
| 2025-09-30 | Date of event requiring the filing of this Schedule 13G Amendment No. 6. |
| 2025-10-17 | Signature date of the Schedule 13G Amendment No. 6 by BlackRock, Inc. |
Keywords
BlackRock, Inspire Medical Systems, Schedule 13G, Institutional Ownership, Common Stock, Medical Devices, Sleep Apnea
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.